2021
DOI: 10.1097/ico.0000000000002792
|View full text |Cite
|
Sign up to set email alerts
|

Letter to the Editor: Immunohistochemical Study of SARS-CoV-2 Viral Entry Factors in the Cornea and Ocular Surface

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 5 publications
0
3
0
Order By: Relevance
“…Correspondingly, conjunctival secretions have been shown to contain SARS-CoV-2 RNA, especially in severely ill patients [30,31], and conjunctivitis related to COVID-19 can occur [32]. However, there is ongoing debate as to whether the conjunctiva can therefore act as a route of infection [33,34]. With regard to corneal tissue, this same question also warrants discussion since it will affect donation practice [35].…”
Section: Discussionmentioning
confidence: 99%
“…Correspondingly, conjunctival secretions have been shown to contain SARS-CoV-2 RNA, especially in severely ill patients [30,31], and conjunctivitis related to COVID-19 can occur [32]. However, there is ongoing debate as to whether the conjunctiva can therefore act as a route of infection [33,34]. With regard to corneal tissue, this same question also warrants discussion since it will affect donation practice [35].…”
Section: Discussionmentioning
confidence: 99%
“…The potential risk of virus transmission from corneal transplantation has been addressed and discussed in several studies [ 1 , 2 , 4 , 5 , 9 , 10 , 13 , 18 ], and there is evidence available to support the potential risk of transmission, as well as evidence against it. No transmission of SARS-CoV-2 from the donor to the recipient has been documented in transplantation procedures carried out to date [ 2 ].…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, former and recent Center for Disease Control (CDC) and Food and Drug Administration (FDA) guidelines do not assume a transmission of a respiratory virus through tissue transplantation including human cells, tissues, cellular, and tissue-based products supported by recent studies [1][2][3]. Nevertheless, the potential presence of viral entry factors in the cornea suggests that infection of human corneal tissue is at least possible [4,5]. In addition, the documented isolation of SARS-CoV-2 from human tears and conjunctival swabs demands to exercise even further caution [6][7][8].…”
Section: Introductionmentioning
confidence: 99%